(Submitted for publication November 27, 1961; accepted January 18, 1962) The presence of circulating autoantibodies in patients with Hashimoto's disease suggests that autoimmunity is implicated in the disease process, but the ultimate proof of an autoimmune pathogenesis of thyroiditis and other human diseases must be obtained by demonstrating the autoaggressive action of antibodies or immunologically competent cells on the living tissue in its normal environment.
The demonstration by Pulvertaft, Doniach, Roitt and Hudson (1, 2) of a serum factor capable of destroying human thyroid cells in tissue culture is an advance in this direction. This finding has been confirmed and amplified by Irvine (3, 4) and by Goudie and McCallum (5) . Further investigations of this phenomenon are reported in the present paper. The cytotoxic factor is shown to be an antibody reacting with the thyroid microsomal antigen; its mode of action has been further studied and its incidence determined in a variety of thyroid conditions and in persons without overt thyroid disease.
METHODS AND MATERIALS
Tissue culture. Primary monolayer cultures of trypsindispersed thyroid epithelium were set up in chambers prepared on microscope slides by the method of Pulvertaft and co-workers (1) . The chambers consisted of a plastic ring attached to a histology slide with silicone grease, and sealed with a coverslip. Fresh thyroid tissue was dispersed for 1 hour in 0.25 per cent trypsin (Difco, 1: 250), and after centrifugation a suitable inoculum was prepared by adding a concentrated suspension of cells to Parker 199 medium until a density of 5 epithelial clumps per field was seen when a drop was viewed through a 1oX objective. The ideal cell concentration resulted in the growth of 30 to 50 cell clumps in a control chamber. Each chamber contained 0.1 ml of test serum, 0.1 ml fresh normal serum, and 0.6 ml of cell inoculum. The fresh normal serum used routinely had a complement titer of between 160 and 320 minimal hemolytic doses (MHD) per ml, as determined by the micromethod of Donnelley (6) , and was known to support good cell growth. Fresh normal serum was always used in tests with serum fractions or absorbed sera. Guinea pig serum could be used as a source of complement but was occasionally cytotoxic. The cultures were incubated for 18 to 24 hours at 370C.
The sensitivity of each gland was established by including as controls known weakly cytotoxic sera and potent Hashimoto sera, sometimes set up in dilutions.
With sensitive glands, all the cells were killed by a strong standard serum; the weaker sera usually allowed a few clumps of cells to be established. Where cells survived in final dilutions of less than 1: 120 of the standard strong serum, the gland was too insensitive to permit evaluation of unknown sera. Provided the gland was sensitive, a serum was judged to be cytotoxic when either no clumps of healthy cells were visible or there was a gross reduction of surviving cells relative to control cultures. All positive sera were retested in at least one subsequent culture.
Zone electrophoresis on "Pevikon" blocks. This was carried out by a method similar to that of MullerEberhard (7) . Approximately 50 g of polyvinyl-chloride powder (Pevikon, Fosfatbolaget, Stockviksverkin, Sweden) washed three times in barbiturate buffer, pH 8.6, was made into a thick slurry and poured into a Perspex trough, 7 X 2 X 1/2 inches. The serum was dialyzed overnight at 40C against the buffer and a trace of bromophenol blue added. After equilibration of the block in the electrode chamber at 4VC for 30 minutes, 1.5 ml of serum was added to a depression in the block, 1 inch from the cathodal end. Electrophoresis was continued for approximately 18 hours in the cold, using a current of 7 ma until the blue-stained albumin was within 1 inch of the anodal end of the block. At the end of electrophoresis the block was cut transversely into six equal portions. The fractions were stirred with 2 ml of Parker's 199 medium in tubes and the supernatant recovered after centrifugation. Each fraction was dialyzed against 250 ml of phosphate-buffered saline at 4°C (8) overnight, then against 10 ml of Parker 199 for 8 hours. The fractions were stored at -20°C until tested.
The protein fractions were identified by immunoelectrophoresis, with Scheidegger's (9) micromethod. Four drops of each fraction in serial fivefold dilutions were set up for tissue culture; 0.2 ml of fresh normal human serum was added to each dilution. A duplicate undiluted tube from each fraction was inactivated at 56°C for 30 minutes before culture to ensure that cytotoxicity was complement dependent.
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THYROID CYTOTOXIC AUTO-ANTIBODY Sodium sulfate precipitation of 'y-globulins from cytotoxic sera. Two vol of 27 per cent sodium sulfate in phosphate buffer, pH 7.8, was added to 1 vol of a cytotoxic serum, over a period of 10 minutes, with continuous stirring. After centrifugation at 10,000 rpm for 10 minutes at room temperature, the supernatant was decanted and saved. The precipitate was washed in 18 per cent sodium sulfate and after centrifugation was dissolved in a volume of distilled water equal to the volume of the supernatant. The solutions were dialyzed against phosphate-buffered saline and Parker's 199 medium for use in the tissue culture test and for the detection of cytoplasmic antibodies by Coons' technique.
Chromatography of -y-globulin obtained by zone electrophoresis on Pezikon blocks. The first three fractions containing y-globulin were used from two Pevikon blocks prepared according to the method described above.
Chromatography was carried out on a diethylaminoethyl (DEAE)-cellulose column by the method of Fahey and Horbett (10) .
The Pevikon fractions were eluted in Parker's 199 medium; the final volume of solution after elution was 9.5 ml. This solution was dialyzed against a 0.01 M phosphate buffer, pH 8.1, overnight.
The column was prepared with DEAE-cellulose from Serva Entwicklungslabor, Heidelberg, and washed through overnight with 0.01 M phosphate buffer. The dialyzed 'y-globulin solution was added to the column and washed on with 1 ml of buffer. A further 48 ml of buffer was passed through the column before gradient elution was begun. (11) . Antibodies to the colloid were demonstrated by alcohol-fixed thyroid sections (12) . The tanned cell hemagglutination (TRC) test for thyroglobulin antibodies was carried out with a formalinized sheep cell preparation (13 Ninety-one control sera from persons without overt thyroid disease were obtained from the antenatal clinic (21 sera) and from the routine pathology laboratory. Diagnoses were obtained from information in the case notes. Sera of 27 blood donors, 8 healthy young adult medical workers, 4 relatives of an 11 year old girl with systemic lupus erythematosus, and 31 hospital patients were also tested. The diagnoses of the latter were: orthopedic conditions (6 cases), gingivitis, hepatic cirrhosis with aplastic anemia, dysmenorrhea, migraine, allergic rhinitis, ulcerative colitis, Addison's disease, parotitis, idiopathic thrombocytopenic purpura, anxiety states (3 cases), hypopituitarism, obesity (2 cases), lupus erythematosus (5 cases), diabetes mellitus, rheumatoid arthritis, ischemic heart disease, hypotension of unknown etiology, and idiopathic hemolytic anemia.
RESULTS
Requirements for complement. Heating cytotoxic serum to 56°C for 30 minutes abolished its cytotoxic effect, and addition of fresh normal human or guinea pig serum to the heated serum restored its potency. The addition of increasing amounts of fresh human serum to a heated cyto-997 Figure 1 . See footnote (*) to Table I. though y-globulin could not always be identified in the eluate by immunoelectrophoresis. Parallel tests for cytoplasmic staining showed a correlation with cytotoxic activity (Table I ). In four other experiments carried out with the same method the cytotoxic activity was found in the same fractions. In two of these experiments the complement-fixing and cytoplasmic antibodies were tested for and found to be contained in the y-globulin fractions. When y-globulin fractions from two Pevikon blocks were chromatographed on DEAE-cellulose, (10) , activity was recovered in the breakthrough peak containing 7S y-globulin ( Figure 1 (Table IV) . A close relationship was found between cytotoxicity and the presence of microsomal CF antibody (Table V) : of 86 sera giving thyroid-specific complement fixation, all were cytotoxic except one serum with a CFT titer of ¼. One other serum, from a patient with nontoxic nodular goiter having a CFT of '/'6, was not cytotoxic. This serum also fixed complement with a saline extract of liver to a titer of ¼ 6 Cytoplasmic antibody was absent in both of these sera. Forty-five weakly cytotoxic sera gave negative results in the CFT when 2 MHD of complement were used for the test. However, when 13 of these sera were retested with 1¼ MHD of complement and a higher antigen concentration, 9 were positive and 4 had become anticomplementary. In view of the difficulties inherent in determining the titer of cytotoxic activity, the correlation coefficient of 0.848 obtained between log (CFT titer) and log (cytotoxic titer) is good (Figure 2, left) .
The fluorescent test appears to be the most sensitive and specific for microsomal antibodies, and results of cytoplasmic staining agreed well with cytotoxic tests (r = 0.895; Figure 2 , right; Table VI ). Of 156 sera tested by both methods, 67 were positive in both, 83 were negative by the two tests, while weak cytoplasmic staining was obtained in 6 sera in which cytotoxicity could not be demonstrated. This apparent greater sensitivity of the fluorescent antibody test is undoubtedly due to the fact that undiluted serum is used, Table VII . Although small proportions of colloid goiter and "normal" tissues were susceptible, they were not satisfactory for testing unknown sera, since cells were not uniformly affected, and a variable number survived in the presence of potent sera. In three cases normal tissues were from the healthy Far weaker staining of the cell cytoplasm was seen with normal controls, although some nonspecific uptake of y-globulin occurred.
Cultures grown in normal serum were tested daily for susceptibility to cytotoxic factor, and the cytoplasmic staining of dried monolayers was compared (Table VIII) . Cytotoxic serum and complement were applied to living cells and incubated for 30 minutes. Characteristic cytolytic changes were seen in 24-hour old monolayers-i.e., condensation and vesiculation of mitochondria, increased density of the nuclear membrane, loss of nuclear structure with final swelling, and rupture of the cells. A few cells remained sensitive in 48-hour old monolayers, but no effects were obtained in older cultures. Fluorescent staining was more specific with direct Hashimoto conjugates, and fluorescence was maximal at 24 hours, decreasing thereafter. The sandwich technique gave bright staining up to 48 hours and then decreased, but some staining was also seen with normal serum in controls.
Clinical incidence of cytotoxic factor. The incidence in various conditions is presented in Table  IX . Cytotoxic factor was demonstrable in all but 2 of 48 Hashimoto subjects. A high incidence was also found in patients with focal thyroiditis, myxedema, and thyrotoxicosis. Weaker cytotoxic activity was demonstrable in a small proportion of patients with colloid goiters and thyroid carcinoma. Only 1 of 8 patients with histologically proven de Quervain's disease had cytotoxic factor. Very weak cytotoxic antibody was found in 1 of 15 mothers of athyreotic cretins and the cytoplasmic staining given by her serum was also weak.
Eight of 91 sera (9 per cent) tested from persons without overt thyroid disease had cytotoxic antibody. In 7 of these the antibodies were weak as judged by their inability to kill all cells in a primary culture. Stronger cytotoxic antibodies were found in a case of acute hemolytic anemia. This serum was titered on a moderately sensitive gland and was completely cytotoxic at % but did not affect the cells significantly at 24-. Serum taken after the hemolytic process had remitted under steroid therapy was barely cytotoxic even to highly susceptible cells. Three of these positive controls were found in a group of 21 pregnant women, and they gave birth to healthy babies. The other positive controls were a 75 year old woman with cardiovascular disease, a woman with other thyroid antibodies whose child had systemic lupus erythematosus, and two healthy subjects. Seven of the 8 cytotoxic control sera were tested for cytoplasmic staining and all gave positive results.
Thirty-four of 118 (29 per cent) close relatives of 54 persons with thyroid disease had cytotoxic antibodies. The highest incidence was found in parents (69 per cent). Twelve of the parents tested were female (cytotoxic factor in 8) and 4 were male (3 cytotoxic). The incidence in siblings and offspring was 26 and 13 per cent, respectively (Table X) .
Cytotoxic activity was present in the sera of only 2 of 7 subjects with systemic lupus erythematosus and these had associated Hashimoto's disease.
DISCUSSION
The antibody nature of the cytotoxic factor was suggested by previous work showing that complement was required for activity and that the effect was organ and species specific (1, 2) . Further support for this view was obtained in the present studies by the results of serum fractionation experiments. The cytotoxic factor was found to be stable at 560C for 30 minutes, disproving the original suggestion that the antibody was heat labile (1). The factor was precipitated together with the y-globulins by salt fractionation. After zone electrophoresis, virtually all of the activity was recovered in the y-globulins; the low cytotoxicity associated with the slow fl-globulin fraction may have been due to traces of y-globulin in concentrations insufficient for detection by immunoelectrophoresis. These findings are at variance with the work of Irvine (4) who failed to isolate the cytotoxic factor in the y-globulin fraction by both paper electrophoresis and Cohn fractionation. On ultracentrifugation the factor was localized in the 7S fraction. Thus the cytotoxic factor has the properties of a normal low-molecular weight immune antibody in its ability to kill the patients' own thyroid cells in culture. Further evidence that the cell surface is the reacting site derives from the studies made with fluorescein-conjugated Hashimoto serum. Inability to penetrate the living cells prevented the serum from staining the cytoplasm in healthy cultures, but faint surface staining was observed. In view of the lack of penetration of antibodies into living cells, the ability of trypsinized cell suspensions to absorb out cytotoxic activity from Hashimoto serum also argues for combination occurring at the cell surface. Previous studies on immune cytolysis with other cell systems such as HeLa cells (18, 19) , and immune hemolysis (20) , have emphasized the importance of cell surface interactions with the antibody. Electron microscope studies using ferritin-labeled antibody to HeLa cells (21) , have shown that antibody combination is restricted to the cell surface until after the addition of complement, when binding to the subcellular elements of the cytoplasm can be observed after rupture of the cell membrane. Thus our tissue culture studies indicate that the same mechanisms obtain in autoimmune cytolysis as in heterologous immune systems.
The alteration of the cell surface apparently required for the demonstration of the cytotoxic effect makes it seem unlikely that normal thyroid cells can react with cytotoxic antibodies in vivo. Passive infusion into a monkey (14) of Hashimoto serum containing high levels of cross-reacting CF antibodies indeed failed to produce thyroid injury. The fact that the cytotoxic antibodies have been demonstrated in two-thirds of thyrotoxic patients who have only a mild and nonprogressive focal thyroiditis also suggests that their presence does not imply progressive tissue destruction.
However, patients with focal thyroiditis have much lower titers of cytotoxic factor than have untreated Hashimoto subjects and it may be that high-titer antibodies act synergistically with sensitized lymphoid cells. The lymphocytes may injure the cell membrane sufficiently [possibly during emperipolesis-i.e., intracellular wandering (1, 2)] to allow the cytotoxic factor to enter into the cytoplasm where it exerts its full effect. It is of interest that Robineaux (22) was able to show by phase-contrast cinemicrography that slight surface injury of white blood corpuscles is sufficient to enable the lupus erythematosus factor to combine with live leukocytes.
The non-organ specific complement-fixing antibodies reacting with thyroid homogenates and with liver or other human and animal organs (AICF) do not produce cytotoxic effects in cultured thyroid cells, as shown by the negative results obtained with systemic lupus erythematosus and other AICF-reacting sera.
Blizzard and colleagues (23) and Beierwaltes, Dodson and Wheeler (24) put forward the suggestion that congenital athyreotic cretinism may be due in some cases to placental transmission of cytotoxic antibodies which presumably kill the fetal thyroid during pregnancy. We therefore tested 15 mother and cretin-baby pairs by tissue culture. Only one of the mothers' sera was weakly cytotoxic. Since similar weak cytotoxicity was demonstrated in 9 per cent of blood donors and mixed hospital patients without overt thyroid disease, the finding in this mother is not significant. Further, three mothers giving birth to healthy infants had cytotoxic antibody during pregnancy. Thus the hypothesis of placental transfer of cytotoxic antibody as a cause of cretinism receives no support from the present studies [see also Parker and Beierwaltes (25) ], although it is conceivable that sensitized lymphocytes may occasionally overcome the placental barrier and destroy the fetal thyroid. shown to be a low-molecular weight y-globulin, further confirming its antibody nature.
2. The cytotoxic antibodies are identical with or very closely related to the antibodies that fix complement in the presence of toxic thyroid microsomes, and are demonstrable by Coons' indirect fluorescent antibody technique in unfixed frozen sections of toxic thyroid tissues.
3. Thyroid glands having a high content of microsomal antigen yielded cells sensitive to the cytotoxic antibody, while insensitive glands had a low antigen content.
4. The cytotoxic antibodies were active against autologous thyroid cells in culture.
5. The loss, with time, in sensitivity of cultures to the cytotoxic antibodies parallels the loss in ability of the cells to stain with specific "antimicrosomal" sera in the Coons' fluorescent antibody technique.
6. Cytotoxic antibodies were found in 29 per cent of close relatives of patients with thyroid disease. Serum from patients with systemic lupus erythematosus was not cytotoxic except in two instances of an associated thyroiditis.
7. No evidence was obtained to support the view that athyreotic cretinism results from transplacental transfer of these cytotoxic antibodies.
